Dose Optimization in 3D Pulsed Dose Rate Brachytherapy for Patients With Locally Advanced Cervical Cancer
Status:
Completed
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
This prospective phase II trial study aims to optimize the increase in dose to the target
volume at high risk (85 to 90 Gy over 90% of its volume) and the intermediate target volume
(60 Gy to 90 % of its volume) in 3D Pulsed Dose Rate Brachytherapy in treating patients with
locally advanced cervical cancer.